SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001773944-19-000002
Filing Date
2019-11-14
Accepted
2019-11-14 17:11:12
Documents
1
Period of Report
2019-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157376945620388.html 4  
1 FORM 4 wf-form4_157376945620388.xml 4 7371
  Complete submission text file 0001773944-19-000002.txt   8892
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Woodard Jr Joseph Paul (Reporting) CIK: 0001773944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 191221538